GGrantIndex
← Leaderboards

Henry Daniell

University Of Central Florida

$12,094,115
Attributed
$17,521,606
Total exposure
5
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.8M · FY200523
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$17,521,606 · 5

By mechanism

R01$17,521,606 · 5

Top collaborators

Others in their field

Top investigators on “Chloroplasts

Research focus

ChloroplastsCostProteinsTherapeutic ProteinPlantsOralAnimal ModelLettuce - DietaryLifeDoseCellsProductionHemophilia APreventOral ToleranceImmune TolerancePharmaceutical PreparationsTransgenic OrganismsBaseAnaphylaxisTissuesCanis FamiliarisAnimalsImmune

Grant awards (33)

Affordable Oral Delivery of Human Therapeutic Proteins Bioencapsulated in Plant Cells$739,713
R01 · FY2023 · HL · contact PI
Affordable Oral Delivery of Human Therapeutic Proteins Bioencapsulated in Plant Cells$739,713
R01 · FY2022 · HL · contact PI
Affordable Oral Delivery of Human Therapeutic Proteins Bioencapsulated in Plant Cells$785,508
R01 · FY2021 · HL · contact PI
Affordable Oral Delivery of Human Therapeutic Proteins Bioencapsulated in Plant Cells$795,892
R01 · FY2020 · HL · contact PI
Oral Tolerance for Hemophilia$746,710
R01 · FY2020 · HL
Oral Tolerance for Hemophilia$779,623
R01 · FY2019 · HL
Affordable oral delivery of human blood protein drugs bioencapsulated in plant cells$726,730
R01 · FY2019 · HL · contact PI
Affordable oral delivery of human blood protein drugs bioencapsulated in plant cells$668,568
R01 · FY2018 · HL · contact PI
Oral Tolerance for Hemophilia$650,568
R01 · FY2018 · HL
Oral therapy for diabetic retinopathy using ACE2/Ang1-7 bioencapsulated in plant cells$407,029
R01 · FY2018 · EY
Affordable oral delivery of human blood protein drugs bioencapsulated in plant cells$688,310
R01 · FY2017 · HL · contact PI
Oral Tolerance for Hemophilia$668,425
R01 · FY2017 · HL
Oral therapy for diabetic retinopathy using ACE2/Ang1-7 bioencapsulated in plant cells$407,029
R01 · FY2017 · EY
Affordable oral delivery of human blood protein drugs bioencapsulated in plant cells$633,875
R01 · FY2016 · HL · contact PI
Oral therapy for diabetic retinopathy using ACE2/Ang1-7 bioencapsulated in plant cells$407,029
R01 · FY2016 · EY
Oral Therapy for Hemophilia A$695,103
R01 · FY2015 · HL
Oral therapy for diabetic retinopathy using ACE2/Ang1-7 bioencapsulated in plant cells$419,529
R01 · FY2015 · EY
Oral Therapy for Hemophilia A$695,227
R01 · FY2014 · HL
Oral immune modulatory therapy using antigens bioencapsulated in plant cells$416,573
R01 · FY2014 · HL · contact PI
Oral Therapy for Hemophilia A$663,208
R01 · FY2013 · HL
Oral immune modulatory therapy using antigens bioencapsulated in plant cells$433,499
R01 · FY2013 · HL · contact PI
Oral Therapy for Hemophilia A$692,419
R01 · FY2012 · HL
Oral immune modulatory therapy using antigens bioencapsulated in plant cells$446,064
R01 · FY2012 · HL · contact PI
Oral Therapy for Hemophilia A$715,070
R01 · FY2011 · HL
Oral immune modulatory therapy using antigens bioencapsulated in plant cells$458,202
R01 · FY2011 · HL · contact PI
Expression of Human Therapeutic Proteins in Transgenic Tobacco Chloroplasts$293,920
R01 · FY2010 · GM · contact PI
Expression of Human Therapeutic Proteins in Transgenic Tobacco Chloroplasts$281,384
R01 · FY2009 · GM · contact PI
Expression of Human Therapeutic Proteins in Transgenic Tobacco Chloroplasts$281,384
R01 · FY2008 · GM · contact PI
Expression of Human Therapeutic Proteins in Transgenic Tobacco Chloroplasts$314,714
R01 · FY2006 · GM · contact PI
Expression of Human Therapeutic Proteins in Chloroplasts$210,270
R01 · FY2005 · GM
Expression of Human Therapeutic Proteins in Chloroplasts$210,270
R01 · FY2004 · GM
Expression of Human Therapeutic Proteins in Chloroplasts$220,482
R01 · FY2003 · GM
Expression of Human Therapeutic Proteins in Chloroplasts$229,566
R01 · FY2002 · GM